---
figid: PMC8037234__ijms-22-03440-g005
figlink: pmc/articles/PMC8037234/figure/ijms-22-03440-f005/
number: Figure 5
caption: E2s participate in the NF-κB pathway. (A) T cell receptor (TCR) stimulation
  promotes the binding of SLP-76 and UBE2I and increases the SUMOylation of SLP-76.
  SLP-76 and UBE2I synergize to augment TCR-mediated IL2 transcription by nuclear
  factor of activated T cells (NFAT) in a manner dependent on SUMOylation of SLP-76
  []. (B) Under the action of the stimulation signal, IκBα will rapidly undergo phosphorylation
  modification under the stimulation of IKK. IKK contains two catalytic subunits,
  IKKα and IKKβ, and one regulatory subunit IKKγ []. In the classical pathway, IKKβ
  phosphorylates IκBα and is then recruited into the SKP1/CUL1/F-box protein (SCF)
  complex via βTrCP containing the F-box domain. βTrCP contains a WD40-repeat domain,
  which can specifically bind to two phosphorylated serine sites on the N-terminus
  of IκBα []. The RING domain contained in ROC1 can recruit E2 and to polyubiquitinylate
  phosphorylated IκBα, so that it is degraded by the 26S proteasome and “releases”
  NF-κB into the nucleus []. (C) In the non-classical pathway, activation of the pathway
  was suggested to depend on receptor-induced TRAF3 degradation and stabilization
  of NF-κB inducing kinase (NIK) []. TRAF3 physically associates with NIK via a specific
  sequence motif located in the N-region of NIK and ubiquitinates NIK to stabilize
  it with UBE2D []. CD40 and B cell activativing factor belonging to the TNF family
  (BAFF) of the tumor necrosis factor (TNFR) superfamily activate NIK selectively,
  and then NIK phosphorylates and activates IKKα. Activated IKKα catalyzes the phosphorylation
  of the two Ser sites at the C-terminus of the p100 precursor protein, and the phosphorylated
  modified p100 is recognized by the SCF-βTrCP complex []. The proteasome only degrades
  the C-terminus of p100 that contains ankyrin repeats, but does not affect the N-terminus
  (that is, the p52 subunit) containing the rel-homology domain (RHD) []. Then, p52
  combines with RelB to form a dimer, which promotes the expression of target genes
  that can mature and activate B cells [].
pmcid: PMC8037234
papertitle: The Molecular Basis of Ubiquitin-Conjugating Enzymes (E2s) as a Potential
  Target for Cancer Therapy.
reftext: Xiaodi Du, et al. Int J Mol Sci. 2021 Apr;22(7):3440.
pmc_ranked_result_index: '63499'
pathway_score: 0.9091961
filename: ijms-22-03440-g005.jpg
figtitle: E2s participate in the NFKB pathway
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8037234__ijms-22-03440-g005.html
  '@type': Dataset
  description: E2s participate in the NF-κB pathway. (A) T cell receptor (TCR) stimulation
    promotes the binding of SLP-76 and UBE2I and increases the SUMOylation of SLP-76.
    SLP-76 and UBE2I synergize to augment TCR-mediated IL2 transcription by nuclear
    factor of activated T cells (NFAT) in a manner dependent on SUMOylation of SLP-76
    []. (B) Under the action of the stimulation signal, IκBα will rapidly undergo
    phosphorylation modification under the stimulation of IKK. IKK contains two catalytic
    subunits, IKKα and IKKβ, and one regulatory subunit IKKγ []. In the classical
    pathway, IKKβ phosphorylates IκBα and is then recruited into the SKP1/CUL1/F-box
    protein (SCF) complex via βTrCP containing the F-box domain. βTrCP contains a
    WD40-repeat domain, which can specifically bind to two phosphorylated serine sites
    on the N-terminus of IκBα []. The RING domain contained in ROC1 can recruit E2
    and to polyubiquitinylate phosphorylated IκBα, so that it is degraded by the 26S
    proteasome and “releases” NF-κB into the nucleus []. (C) In the non-classical
    pathway, activation of the pathway was suggested to depend on receptor-induced
    TRAF3 degradation and stabilization of NF-κB inducing kinase (NIK) []. TRAF3 physically
    associates with NIK via a specific sequence motif located in the N-region of NIK
    and ubiquitinates NIK to stabilize it with UBE2D []. CD40 and B cell activativing
    factor belonging to the TNF family (BAFF) of the tumor necrosis factor (TNFR)
    superfamily activate NIK selectively, and then NIK phosphorylates and activates
    IKKα. Activated IKKα catalyzes the phosphorylation of the two Ser sites at the
    C-terminus of the p100 precursor protein, and the phosphorylated modified p100
    is recognized by the SCF-βTrCP complex []. The proteasome only degrades the C-terminus
    of p100 that contains ankyrin repeats, but does not affect the N-terminus (that
    is, the p52 subunit) containing the rel-homology domain (RHD) []. Then, p52 combines
    with RelB to form a dimer, which promotes the expression of target genes that
    can mature and activate B cells [].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNF
  - IL1A
  - IL1B
  - IRF6
  - CD40LG
  - TNFSF13B
  - LTBR
  - TRA
  - TRB
  - TRD
  - TRG
  - CD40
  - TRADD
  - BCR
  - BCL10
  - TNFAIP3
  - UBE2N
  - TRAF6
  - UBE2V1
  - CYLD
  - NLK
  - MAP3K7CL
  - LCP2
  - CHUK
  - IKBKB
  - IKBKG
  - NFKBIA
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - UPP1
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - IL2
  - TRAF3
  - TRAF2
  - TRAF5
  - TCR
  - Lys
  - C
  - LPS
  - CIAP
genes:
- word: TNF
  symbol: TNF
  source: hgnc_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1A
  entrez: '3552'
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: LPS,mRNA
  symbol: LPS
  source: hgnc_prev_symbol
  hgnc_symbol: IRF6
  entrez: '3664'
- word: LT,CD40L,BAFF/BLys
  symbol: CD40L
  source: hgnc_alias_symbol
  hgnc_symbol: CD40LG
  entrez: '959'
- word: LT,CD40L,BAFF/BLys
  symbol: BLYS
  source: hgnc_alias_symbol
  hgnc_symbol: TNFSF13B
  entrez: '10673'
- word: LT,CD40L,BAFF/BLys
  symbol: BAFF
  source: hgnc_alias_symbol
  hgnc_symbol: TNFSF13B
  entrez: '10673'
- word: LTBR
  symbol: LTBR
  source: hgnc_symbol
  hgnc_symbol: LTBR
  entrez: '4055'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: CD40
  symbol: CD40
  source: hgnc_symbol
  hgnc_symbol: CD40
  entrez: '958'
- word: TRADD
  symbol: TRADD
  source: hgnc_symbol
  hgnc_symbol: TRADD
  entrez: '8717'
- word: BCR
  symbol: BCR
  source: hgnc_symbol
  hgnc_symbol: BCR
  entrez: '613'
- word: CIAP
  symbol: CLAP
  source: hgnc_alias_symbol
  hgnc_symbol: BCL10
  entrez: '8915'
- word: A20
  symbol: A20
  source: hgnc_alias_symbol
  hgnc_symbol: TNFAIP3
  entrez: '7128'
- word: UBE2N
  symbol: UBE2N
  source: hgnc_symbol
  hgnc_symbol: UBE2N
  entrez: '7334'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: UBE2V1
  symbol: UBE2V1
  source: hgnc_symbol
  hgnc_symbol: UBE2V1
  entrez: '7335'
- word: CYLD
  symbol: CYLD
  source: hgnc_symbol
  hgnc_symbol: CYLD
  entrez: '1540'
- word: NIK
  symbol: NLK
  source: hgnc_symbol
  hgnc_symbol: NLK
  entrez: '51701'
- word: TAKI
  symbol: TAKL
  source: hgnc_alias_symbol
  hgnc_symbol: MAP3K7CL
  entrez: '56911'
- word: TAKI
  symbol: TAKL
  source: hgnc_alias_symbol
  hgnc_symbol: MAP3K7CL
  entrez: '56911'
- word: SLP-76
  symbol: SLP-76
  source: hgnc_alias_symbol
  hgnc_symbol: LCP2
  entrez: '3937'
- word: CYLD
  symbol: CYLD
  source: hgnc_symbol
  hgnc_symbol: CYLD
  entrez: '1540'
- word: IKKa
  symbol: IKKA
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: IKKB
  symbol: IKKB
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: NIK
  symbol: NLK
  source: hgnc_symbol
  hgnc_symbol: NLK
  entrez: '51701'
- word: NEMO
  symbol: NEMO
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: IKKA
  symbol: IKKA
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: NIK
  symbol: NLK
  source: hgnc_symbol
  hgnc_symbol: NLK
  entrez: '51701'
- word: IKBa
  symbol: IKBA
  source: hgnc_alias_symbol
  hgnc_symbol: NFKBIA
  entrez: '4792'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: UPP
  symbol: UPP
  source: hgnc_alias_symbol
  hgnc_symbol: UPP1
  entrez: '7378'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC1
  entrez: '4772'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC2
  entrez: '4773'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC3
  entrez: '4775'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC4
  entrez: '4776'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFAT5
  entrez: '10725'
- word: NIK
  symbol: NLK
  source: hgnc_symbol
  hgnc_symbol: NLK
  entrez: '51701'
- word: UPP
  symbol: UPP
  source: hgnc_alias_symbol
  hgnc_symbol: UPP1
  entrez: '7378'
- word: IKBa
  symbol: IKBA
  source: hgnc_alias_symbol
  hgnc_symbol: NFKBIA
  entrez: '4792'
- word: NF-KB2
  symbol: NFKB2
  source: hgnc_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: IKBa
  symbol: IKBA
  source: hgnc_alias_symbol
  hgnc_symbol: NFKBIA
  entrez: '4792'
- word: RelB
  symbol: RELB
  source: hgnc_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: NF-KB2
  symbol: NFKB2
  source: hgnc_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC1
  entrez: '4772'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC2
  entrez: '4773'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC3
  entrez: '4775'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC4
  entrez: '4776'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFAT5
  entrez: '10725'
- word: RelB
  symbol: RELB
  source: hgnc_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: IL-2
  symbol: IL-2
  source: hgnc_alias_symbol
  hgnc_symbol: IL2
  entrez: '3558'
- word: TRAF3
  symbol: TRAF3
  source: hgnc_symbol
  hgnc_symbol: TRAF3
  entrez: '7187'
- word: TRAF3
  symbol: TRAF3
  source: hgnc_symbol
  hgnc_symbol: TRAF3
  entrez: '7187'
- word: TRAF2/6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: TRAF2/6
  symbol: TRAF2
  source: hgnc_symbol
  hgnc_symbol: TRAF2
  entrez: '7186'
- word: TRAF2/5
  symbol: TRAF2
  source: hgnc_symbol
  hgnc_symbol: TRAF2
  entrez: '7186'
- word: TRAF2/5
  symbol: TRAF5
  source: hgnc_symbol
  hgnc_symbol: TRAF5
  entrez: '7188'
chemicals:
- word: TCR
  source: MESH
  identifier: D017260
- word: Lys
  source: MESH
  identifier: C026591
- word: C
  source: MESH
  identifier: D002244
diseases:
- word: LPS
  source: MESH
  identifier: C536528
- word: CIAP
  source: ''
  identifier: ''
---
